Pharmaceutical research and development
Release Time：2017-03-15
Jiangsu Kell Medical Technology Co., Ltd.
Jiangsu Wei Kell Pharmaceutical Technology Co Ltd is an innovative drug development and domestic / international transfer, pharmaceutical intermediates research and development, production and sales as well as generic development, approval and transfer based high-tech bio pharmaceutical enterprises. Wiker currently has more than 90 R & D technicians, equipped with a full range of synthetic laboratories, pharmaceutical and pharmaceutical analysis laboratory, and the use of international advanced management and operation mode. Wiker cumulative application for invention patents at home and abroad 23 (7 have been authorized), PCT patent application of the 4 (the 1 has entered the stage of foreign countries, the United States has authorized), a total of national, provincial and municipal government fund of 12.
Center for drug research and development
Drug research and development center was established in 2006, is a biotechnology drugs, modern Chinese medicine and health food research based drug research and development institutions. Existing R & D personnel more than 40 people, with advanced R & D equipment and in line with the GMP certification standards in the test run. The research projects in short, medium and long-term combination: a class of drugs -- people with avian influenza (H5N1) virus inactivated vaccine (Vero cell) has obtained the drug clinical trial document issued by the State Food and drug administration, is currently in phase I clinical trials; micro carrier rabies vaccine project has completed all preclinical studies and clinical trials reporting documents; MDCK cells of seasonal influenza vaccine project, human diploid cell rabies vaccine project also in the development process, and has won the "influenza virus vaccine strain adaptation method" on Vero cells and Vero cell vaccine preparation method of "two national invention patents.
